Home Cart 0 Sign in  
X

[ CAS No. 3551-55-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3551-55-1
Chemical Structure| 3551-55-1
Chemical Structure| 3551-55-1
Structure of 3551-55-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3551-55-1 ]

Related Doc. of [ 3551-55-1 ]

Alternatived Products of [ 3551-55-1 ]

Product Details of [ 3551-55-1 ]

CAS No. :3551-55-1 MDL No. :MFCD00056028
Formula : C6H8N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :KEVRHVMWBKFGLO-UHFFFAOYSA-N
M.W : 140.14 Pubchem ID :137976
Synonyms :

Calculated chemistry of [ 3551-55-1 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 35.02
TPSA : 44.24 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.0
Log Po/w (XLOGP3) : 1.11
Log Po/w (WLOGP) : 0.49
Log Po/w (MLOGP) : -0.52
Log Po/w (SILICOS-IT) : 0.85
Consensus Log Po/w : 0.79

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.72
Solubility : 2.67 mg/ml ; 0.019 mol/l
Class : Very soluble
Log S (Ali) : -1.63
Solubility : 3.27 mg/ml ; 0.0233 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.88
Solubility : 1.84 mg/ml ; 0.0132 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.98

Safety of [ 3551-55-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3551-55-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3551-55-1 ]
  • Downstream synthetic route of [ 3551-55-1 ]

[ 3551-55-1 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 3551-55-1 ]
  • [ 696-07-1 ]
Reference: [1] Synthetic Communications, 1988, vol. 18, # 8, p. 855 - 868
  • 2
  • [ 3934-20-1 ]
  • [ 124-41-4 ]
  • [ 22536-63-6 ]
  • [ 3551-55-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 149 - 153
  • 3
  • [ 6320-15-6 ]
  • [ 3551-55-1 ]
YieldReaction ConditionsOperation in experiment
92% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium tetrahydroborate; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at 25℃; for 7 h; Inert atmosphere General procedure: PdCl2(dppf), PdCl2(tbpf) and (A.caPhos)PdCl2. A mixture of the halogenated heterocycle (0.66 mmol) in anhydrous THF (13.2 mL) was degassed by bubbling argon for few minutes. Then, PdCl2(dppf) (27.0 mg, 0.033 mmol, 5.0 molpercent), TMEDA (0.130 g, 1.12 mmol, 1.7 equiv) and finally NaBH4 (42.4 mg, 1.12 mmol, 1.7 equiv) were introduced in sequence. The mixture was stirred at room temperature under argon for the proper time and then worked up as described above.
Reference: [1] Journal of Molecular Catalysis A: Chemical, 2014, vol. 393, p. 191 - 209
[2] Journal of Organic Chemistry, 1955, vol. 20, p. 829,833,835
  • 4
  • [ 56686-16-9 ]
  • [ 176643-32-6 ]
  • [ 3551-55-1 ]
  • [ 1017841-99-4 ]
YieldReaction ConditionsOperation in experiment
36%
Stage #1: With magnesium; ethylene dibromide In tetrahydrofuran for 3 h; Reflux; Inert atmosphere
Stage #2: at -10 - 20℃; Inert atmosphere
Stage #3: With ammonia; copper diacetate In 1,4-dioxane; dichloromethane; water at 20℃; for 24 h;
(CH2)2Br2 was added in 5 portions (60 μl per 30 min, 3.5 mmol) to a refluxed mixture of 8 (500 mg, 2.3 mmol), Mg (168 mg, 6.9 mmol) and dry THF (10 mL) under argon. When 8 had disappeared (TLC, hexane; after ca. 3 h), the mixture was cooled to -10 °C and compound 3 (339 mg, 1.5 mmol) was added. After stirring for 2 h at -10 °C, the mixture was allowed to warm to room temperature, stirred overnight and filtered through a Celite.(R). pad. The filtrate was concentrated to dryness. The residue was treated with Cu(OAc)2/NH3 (aq) under the conditions described in Ref. 28. Column chromatography (CHCl3/acetone, 85/15, v/v) gave 10 (126 mg, 39percent) and 11 (197 mg, 36percent, mp 151-152 °C).
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 16, p. 1866 - 1870
  • 5
  • [ 56686-16-9 ]
  • [ 176643-32-6 ]
  • [ 3551-55-1 ]
  • [ 1017841-99-4 ]
  • [ 1294479-78-9 ]
YieldReaction ConditionsOperation in experiment
39%
Stage #1: With tert.-butyl lithium In tetrahydrofuran; pentane at -78℃; for 0.5 h; Inert atmosphere
Stage #2: at -78 - 20℃; Inert atmosphere
Stage #3: With ammonia; copper diacetate In 1,4-dioxane; dichloromethane; water at 20℃; for 24 h;
t-BuLi (Aldrich; 1.7 M soln in pentane, 1.1 mL) was added to a mixture of 8 (Aldrich; 200 mg, 0.9 mmol) and dry THF (2 mL) at -78 °C under argon. The mixture was left at -78 °C for 30 min and then compound 3 (190 mg, 0.8 mmol) was added. The mixture was allowed to warm to room temperature. The reaction was followed by TLC (CHCl3/acetone, 85/15, v/v) at 30 min intervals. After stirring for 3 h at room temperature, when 3 was no longer detected by TLC, Et2O (20 mL) was added. The mixture was washed with H2O (5 mL) and evaporated to dryness. The residue was dissolved in 1,4-dioxane (6 mL) and CH2Cl2 (2 mL). Cu(OAc)2 (40 mg), NH3 (aq) (0.3 mL) and H2O (1 mL) were added. The mixture was stirred at room temperature for 1 d. The organic layer was separated, washed with H2O (10 mL), dried (MgSO4) and concentrated to dryness. Column chromatography of the residue (CHCl3/acetone, 85/15, v/v) gave 9 (70 mg, 39percent), 10 (89 mg, 71percent), and 11 (50 mg, 17percent). 9: A white solid (mp >180 °C, dec). δH (CDCl3, 200 MHz) 1.43-1.56 (16H, m), 1.90 (4H, m), 2.35 (4H, m), 3.29 (4H, m), 3.56 and 4.34 (8H, AB quartet, 2JAB 11.4 Hz); δC (CDCl3, 50 MHz) 22.34, 22.58, 25.42, 26.16, 27.48, 28.49, 36.98, 64.28, 66.43, 72.57, 98.80, 136.38; νmax (KBr) 2936, 2860, 1496, 1448, 1380, 1240, 1156, 1044, 920; HRMS (EI, 70 eV) m/z calcd for C24H36O6N2 (M+) 448.2573, found 448.2557. 11: A white solid (mp 151-152 °C). δH (CDCl3, 200 MHz) 1.34-1.84 (8H, m), 2.1 (2H, m), 2.39 (2H, m), 3.12 (2H, m), 3.63 and 4.57 (4H, AB quartet, 2JAB 11.4), 4.00 (3H, s), 4.02 (3H, s), 10.09 (1H, s); δC (CDCl3, 50 MHz) 22.39, 22.67, 25.49, 27.42, 28.21, 28.84, 37.29, 54.21, 55.19, 64.36, 72.23, 98.77, 105.98, 136.72, 159.26, 165.04, 167.74; νmax (KBr) 2948, 2936, 1716, 1688, 1556, 1536, 1480, 1464, 1356, 1252, 1244, 1108; HRMS (EI, 70 eV) m/z calcd for C18H25O5N3 (M+) 363.1794, found 363.1812. The NMR spectra of 10 were consistent with those described: H. Pelissier, J. Rodriguez and K.P.C. Volhardt, Chem. Eur. J. 5 (1999), p. 3549. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (27)
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 16, p. 1866 - 1870
  • 6
  • [ 3934-20-1 ]
  • [ 141-52-6 ]
  • [ 3551-55-1 ]
Reference: [1] Journal of the American Chemical Society, 1980, vol. 102, p. 916
  • 7
  • [ 18002-25-0 ]
  • [ 77-78-1 ]
  • [ 615-77-0 ]
  • [ 3551-55-1 ]
  • [ 874-14-6 ]
  • [ 7152-66-1 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 29, p. 6848 - 6854
  • 8
  • [ 3934-20-1 ]
  • [ 3551-55-1 ]
Reference: [1] Patent: US2003/147845, 2003, A1,
  • 9
  • [ 3934-20-1 ]
  • [ 124-41-4 ]
  • [ 3551-55-1 ]
Reference: [1] Journal of the American Chemical Society, 1930, vol. 52, p. 2001,2006
  • 10
  • [ 56686-16-9 ]
  • [ 79-35-6 ]
  • [ 3551-55-1 ]
  • [ 83107-54-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1982, vol. 25, # 11, p. 1329 - 1334
  • 11
  • [ 124-41-4 ]
  • [ 2802-61-1 ]
  • [ 3551-55-1 ]
  • [ 39030-96-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 149 - 153
  • 12
  • [ 67-56-1 ]
  • [ 66-22-8 ]
  • [ 3551-55-1 ]
Reference: [1] Synthesis, 1988, # 10, p. 771 - 775
  • 13
  • [ 3934-20-1 ]
  • [ 124-41-4 ]
  • [ 22536-63-6 ]
  • [ 3551-55-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 149 - 153
  • 14
  • [ 3551-55-1 ]
  • [ 56686-16-9 ]
Reference: [1] Organic Letters, 2008, vol. 10, # 9, p. 1715 - 1718
[2] Australian Journal of Chemistry, 2015, vol. 68, # 2, p. 254 - 255
  • 15
  • [ 3551-55-1 ]
  • [ 68-12-2 ]
  • [ 52606-02-7 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 6, p. 1831 - 1835
  • 16
  • [ 186581-53-3 ]
  • [ 3551-55-1 ]
  • [ 124-38-9 ]
  • [ 15400-58-5 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 6, p. 1831 - 1835
  • 17
  • [ 3551-55-1 ]
  • [ 52522-99-3 ]
Reference: [1] Synthetic Communications, 1988, vol. 18, # 8, p. 855 - 868
[2] Synthesis, 1988, # 10, p. 771 - 775
  • 18
  • [ 3551-55-1 ]
  • [ 69696-44-2 ]
  • [ 52522-99-3 ]
Reference: [1] Chemistry - A European Journal, 2009, vol. 15, # 39, p. 10280 - 10290
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3551-55-1 ]

Ethers

Chemical Structure| 186435-66-5

[ 186435-66-5 ]

6-Amino-2-methoxypyrimidin-4-ol

Similarity: 0.85

Chemical Structure| 60186-89-2

[ 60186-89-2 ]

4-Bromo-2,6-dimethoxypyrimidine

Similarity: 0.83

Chemical Structure| 120129-83-1

[ 120129-83-1 ]

2,4-Dimethoxy-5,6-dimethylpyrimidine

Similarity: 0.80

Chemical Structure| 6320-15-6

[ 6320-15-6 ]

4-Chloro-2,6-dimethoxypyrimidine

Similarity: 0.80

Chemical Structure| 5270-94-0

[ 5270-94-0 ]

4,6-Dimethoxypyrimidine

Similarity: 0.79

Related Parent Nucleus of
[ 3551-55-1 ]

Pyrimidines

Chemical Structure| 186435-66-5

[ 186435-66-5 ]

6-Amino-2-methoxypyrimidin-4-ol

Similarity: 0.85

Chemical Structure| 60186-89-2

[ 60186-89-2 ]

4-Bromo-2,6-dimethoxypyrimidine

Similarity: 0.83

Chemical Structure| 120129-83-1

[ 120129-83-1 ]

2,4-Dimethoxy-5,6-dimethylpyrimidine

Similarity: 0.80

Chemical Structure| 6320-15-6

[ 6320-15-6 ]

4-Chloro-2,6-dimethoxypyrimidine

Similarity: 0.80

Chemical Structure| 5270-94-0

[ 5270-94-0 ]

4,6-Dimethoxypyrimidine

Similarity: 0.79